MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Levodopa(L-dopa)"

  • 2018 International Congress

    Impulse control disorders could be accompanied by hypomanic state under intestinal levodopa infusion

    K. Kashihara, M. Kitayama (Okayama, Japan)

    Objective: To determine characteristics of parkinsonian patients under levodopa/carbidopa intestinal gel (LCIG) infusion who present impulse control disorders (ICDs). Background: ICDs may be induced by…
  • 2018 International Congress

    Cerebral and pulmonary thromboembolism in a patient with hyperhomocystinemia treated with high dose levodopa/carbidopa intestinal gel

    E. Saka Topcuoglu, L. Mehdikhanova, E. Arsava, M. Topcuoglu, B. Elibol (Ankara, Turkey)

    Objective: We report a case that developed cerebral and pulmonary thromboembolism during 24-hour levodopa/carbidopa intestinal gel (LCIG) infusion. Background: LCIG is a therapeutic option in…
  • 2018 International Congress

    The hardest symptoms that bother patients with Parkinson’s disease before and 3 months after Deep brain stimulation and Continuous infusion of levodopa-carbidopa intestinal therapy

    V. Vuletic (Rijeka, Croatia)

    Objective: In this study we want to see what are the hardest and the most troublesome symptoms perceived by patients with Parkinson’s disease (PD) before…
  • 2018 International Congress

    Integrated Complimentary Yoga and Ayurveda Treatment Confers Significant Benefits in PD Patients

    H. Babu, U. Kumbhare, T. Raju, N. R, N. R (Bengaluru, India)

    Objective: The present study was carried out to evaluate the efficacy of integrated complimentary Yoga & Ayurveda treatment in improving the motor symptoms and also…
  • 2018 International Congress

    Gait disorders in Parkinson’s disease: 19 observations at the University Hospital Center of Conakry

    F. Sakadi, C. Abass, T. Rahamatou, B. Talibé, N. Woga, B. Kenda, C. Amara (Conakry, Guinea)

    Objective: We report the cases in order to make a clinical and evolutionary evaluation of this pathology. Background: Gait disorders are more and more reported…
  • 2018 International Congress

    Weight loss and nutritional status in Parkinson’s disease patients under levodopa/carbidopa intestinal gel infusion treatment

    M. Fabbri, M. Zibetti, L. Beccaria, A. Romagnolo, E. Montanaro, J. Ferreira, L. Lopiano (Lisbon, Portugal)

    Objective: To investigate the occurrence of weight loss (WL) in Parkinson’s disease (PD) patients under LCIG treatment and to analyse its relationship with the nutritional…
  • 2018 International Congress

    Clinical experiences in Whole systems Ayurveda Management of Parkinson’s Disease

    P. Shankar, P. R, P. Devkumar, A. Godbole, U. Muthane (Bangalore, India)

    Objective: PD Assessment of Ayurveda management using UPDRS -Motor, Hoehn & Yahr staging, Activity of Daily Living % (ADL). Background: Ayurveda holistic management comprises an…
  • 2018 International Congress

    Sensory signs and neuropathic pain in advanced Parkinson’s disease under levodopa treatment

    A.E. Elia, G. Devigili, M. Damasco, L.M. Romito, P. Soliveri, S. Rinaldo, M. Falsitta, R. Eleopra (Milan, Italy)

    Objective: To evaluate whether patients affected by Parkinson’s disease (PD) under levodopa/carbidopa intestinal gel (LCIG) therapy have alterations in sensory symptoms and signs and/or painful…
  • 2018 International Congress

    Does the effect of continuous levodopa infusion treatment for Parkinson’s disease regress as the day progresses?

    I. Thomas, M. Memedi, D. Nyholm, J. Westin (Borlange, Sweden)

    Objective: The goal of this project is to examine if there is evidence to suggest that there is a difference in response to levodopa during…
  • 2018 International Congress

    Epidemiological and clinical profile of Parkinson’s disease in Douala

    J. Doumbe, H. Bohongwe, Y. Mapoure, C. Kuate (Douala, Cameroon)

    Objective: The aim of our study was to determine the hospital prevalence and describe the epidemiological and clinical profile of Parkinson’s disease in Douala Background:…
  • « Previous Page
  • 1
  • …
  • 52
  • 53
  • 54
  • 55
  • 56
  • …
  • 70
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley